跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要核心是混杂、选择、中介和干预下风险预测,直接涉及因果推断。

反馈分类问题

The risks of risk assessment: causal blind spots when using prediction models for treatment decisions

风险评估的风险:用预测模型作治疗决策时的因果盲点

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Nan van Geloven
Ruth H Keogh
Giovanni Cinà
Jesse H. Krijthe
Niels Peek
Kim Luijken
Sara Magliacane
Paweł Morzywołek
Thijs van Ommen
Hein Putter
Matthew Sperrin
Junfeng Wang
Daniala L. Weir
Vanessa Didelez

风险评估的风险:用预测模型作治疗决策时的因果盲点

研究问题
当预测模型用包含既往治疗的观察数据开发时,所得风险如何被误解为治疗决策依据,哪些处理治疗变量的方法存在因果盲点?
方法与思路
作者分析将治疗纳入预测变量、限制治疗组和忽略治疗三种做法,以真实例子讨论混杂、选择、中介及治疗方案变化。
材料陈述的贡献
摘要提出明确目标人群和预测成立的治疗条件,并倡导在开发及评估中使用因果方法,提供各干预选项下的风险预测。
阅读关注点
应核对案例中的风险目标、历史治疗的因果位置,以及观察风险与干预下风险的差异和实现后者所需的数据条件。
阅读边界
这是 arXiv 预印本,同行评审及期刊接收未核实;摘要未提供统一识别条件或新估计器,无法判断具体模型是否适合治疗选择。

原文摘要

Clinicians increasingly rely on prediction models to guide treatment choices. Most prediction models, however, are developed using observational data that include some patients who have already received the treatment the prediction model is meant to inform. Special attention to the causal role of those earlier treatments is required when interpreting the resulting predictions. We identify 'causal blind spots' in three common approaches to handling treatment when developing a prediction model: including treatment as a predictor, restricting to individuals taking a certain treatment, and ignoring treatment. Through several real examples, we illustrate how the risks obtained from models developed using such approaches may be misinterpreted and can lead to misinformed decision-making. Our discussion covers issues attributable to confounding, selection, mediation and changes in treatment protocols over time. We advocate for an extension of guidelines for the development, reporting and evaluation of prediction models to avoid such misinterpretations. Developers must ensure that the intended target population for the model, and the treatment conditions under which predictions hold, are clearly communicated. When prediction models are intended to inform treatment decisions, they need to provide estimates of risk under the specific treatment (or intervention) options being considered, known as 'prediction under interventions'. Next to suitable data, this requires causal reasoning and causal inference techniques during model development and evaluation. Being clear about what a given prediction model can and cannot be used for prevents misinformed treatment decisions and thereby prevents potential harm to patients.

笔记与分组